Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1508 Articles

Chris Lange | Oct 10, 2019 at 9:40 AM EDT

Big Pharma Sees Rising Tide in Short Interest

The September 30 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Oct 10, 2019 at 7:05 AM EDT

5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Microsoft, Intel and Pfizer above all other Dow stocks.

Lee Jackson | Sep 30, 2019 at 7:30 AM EDT

5 Dow Jones Industrial Average 2019 Laggards Could Be Big Q4 Winners

The last thing investors want is a value trap loser that stays stagnant, but all these top companies have solid…

Chris Lange | Sep 27, 2019 at 9:55 AM EDT

Good News for Teens Suffering Atopic Dermatitis

Pfizer has announced positive top-line results from a second Phase 3 pivotal study evaluating abrocitinib, in patients aged 12 and…

Chris Lange | Sep 25, 2019 at 9:20 AM EDT

Short Sellers Grow More Selective in Big Pharma

The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Trey Thoelcke | Sep 25, 2019 at 6:35 AM EDT

The 6 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Pfizer, Intel and Microsoft above all other Dow stocks.

Chris Lange | Sep 12, 2019 at 8:35 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Pharma

The August 30 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Sep 12, 2019 at 6:50 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Pfizer, Intel and Microsoft above all other Dow stocks.

Chris Lange | Aug 27, 2019 at 8:35 AM EDT

Big Pharma Sees a Rising Tide in Short Interest

The August 15 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Aug 27, 2019 at 6:35 AM EDT

The 6 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Intel, Pfizer and Microsoft above all other Dow stocks.

Jon C. Ogg | Aug 12, 2019 at 12:10 PM EDT

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current…

Chris Lange | Aug 12, 2019 at 8:40 AM EDT

Major Pharma Sees Rising Tide in Short Interest

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Aug 12, 2019 at 6:35 AM EDT

Pfizer Once Again the Most Shorted Dow Stock

As of the most recently reported period, short sellers still favored Pfizer, Intel and Microsoft above all other Dow stocks.

Jon C. Ogg | Aug 8, 2019 at 1:05 PM EDT

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

Of the 40 worst performers in the S&P 500 so far in 2019, 11 are tied to oil and gas,…

Chris Lange | Aug 5, 2019 at 10:45 AM EDT

Is GlycoMimetics’ Sickle Cell Study Done For?

GlycoMimetics shares were crushed on Monday after the firm announced late-stage results from its sickle cell disease trial in conjunction…

1 … 27 28 29 30 31 … 101

Pfizer : PFE

All Pfizer Articles

Big Pharma Sees Rising Tide in Short Interest

5 Most Shorted Dow Stocks

5 Dow Jones Industrial Average 2019 Laggards Could Be Big Q4 Winners

Good News for Teens Suffering Atopic Dermatitis

Short Sellers Grow More Selective in Big Pharma

The 6 Most Shorted Dow Stocks

Short Sellers Can’t Make Up Their Minds on Big Pharma

The 5 Most Shorted Dow Stocks

Big Pharma Sees a Rising Tide in Short Interest

The 6 Most Shorted Dow Stocks

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Major Pharma Sees Rising Tide in Short Interest

Pfizer Once Again the Most Shorted Dow Stock

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

Is GlycoMimetics’ Sickle Cell Study Done For?

VOO Just Crossed $1 Trillion. Here’s the Hidden Risk Nobody’s Pricing In

Why the Pure Bitcoin-Miner Fund Crushed the Blockchain Basket, Up 184%

Why Age 63 Is the Most Expensive Year to Touch Your IRA (Medicare Looks Back Two Years)

Why Age 63 Is the Most Expensive Year to Touch Your IRA (Medicare Looks Back Two Years)

"100 Million Percent Wrong" Suze Orman Rages At Social Security Expert's "Crazy" Advice

VOO Just Crossed $1 Trillion. Here’s the Hidden Risk Nobody’s Pricing In

Why the Pure Bitcoin-Miner Fund Crushed the Blockchain Basket, Up 184%

Pfizer : PFE

All Pfizer Articles

Big Pharma Sees Rising Tide in Short Interest

5 Most Shorted Dow Stocks

5 Dow Jones Industrial Average 2019 Laggards Could Be Big Q4 Winners

Good News for Teens Suffering Atopic Dermatitis

Short Sellers Grow More Selective in Big Pharma

The 6 Most Shorted Dow Stocks

Short Sellers Can’t Make Up Their Minds on Big Pharma

The 5 Most Shorted Dow Stocks

Big Pharma Sees a Rising Tide in Short Interest

The 6 Most Shorted Dow Stocks

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Major Pharma Sees Rising Tide in Short Interest

Pfizer Once Again the Most Shorted Dow Stock

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

Is GlycoMimetics’ Sickle Cell Study Done For?

VOO Just Crossed $1 Trillion. Here’s the Hidden Risk Nobody’s Pricing In

Why the Pure Bitcoin-Miner Fund Crushed the Blockchain Basket, Up 184%

Why Age 63 Is the Most Expensive Year to Touch Your IRA (Medicare Looks Back Two Years)

Featured Reads

Why Age 63 Is the Most Expensive Year to Touch Your IRA (Medicare Looks Back Two Years)

"100 Million Percent Wrong" Suze Orman Rages At Social Security Expert's "Crazy" Advice